Hpv vagy mycosis
Leírás: Papilocare is a gel vaginally administered by a singledose cannula.
Vaginal gel formulation is effective as a local treatment with controlled systemic absorption and rapid and efficient distribution Jogosultság Kritériumok: Inclusion Criteria: 1. Woman between the ages of 30 and 65 both inclusive. Acceptance in the participation of the essay and signature of the Informed Consent form.
Is capable, at the discretion of the researcher, to comply with the requirements of the trial and without hindrance to follow the instructions and assessments throughout it. Exclusion Criteria: 1.
- A leggyakoribb hüvelyfertőzések
- Hpv fiatal férfiaknál
- Emberekben a helminták kezelése
- A betegség könnyen terjed birkózók között.
Clinically relevant immune system alterations, or any other autoimmune disease or in treatment with immunosuppressants. Non-diagnosed abnormal genital hemorrhage during the 6 months prior to the screening visit.
The Human Papillomavirus (HPV) Vaccination and Cervical Cancer
To had been vaccinated against HPV. Other symptomatic vulvovaginal infections. Surgical cervical excision in the last year or total hysterectomy.
Previous history of gynecological cancer. Participation in any other clinical trial at present or in the 4 weeks prior to the inclusion of the trial.
HPV szemölcs lehet a talpamon és végbelemnél?
Any planned surgery that prevents the correct compliance with the guidelines. Use of vaginal contraceptives or other vaginal hormonal treatments.
Contraindications for the use of Papilocare® gel or known allergies to any of its components. Women of childbearing age who do not use effective contraceptive methods, pregnant women, with suspicion of pregnancy or woman hpv vagy mycosis are breastfeeding.